Prothrombin Time (PT)

Reference Ranges
Prothrombin Time
Adult ( > 16y) 10.00 TO 13.00 seconds
Conditions

 

References

  1. ^ Fritsma, George A. "Evaluation of Hemostasis." Hematology: Clinical Principles and Applications . Ed. Bernadette Rodak. W.B. Saunders Company: Philadelphia, 2002. 719-53. Print
  2. ^ Goljan, Edward (2010). Edward Goljan. ed (in English). Rapid Review Pathology (3rd ed.). Philadelphia, PA, USA: Mosby. ISBN 978-0-323-06862-8. 
  3. ^ Della Valle P, Crippa L, Garlando AM, et al. (December 1999). "Interference of lupus anticoagulants in prothrombin time assays: implications for selection of adequate methods to optimize the management of thrombosis in the antiphospholipid-antibody syndrome" (PDF). Haematologica 84 (12): 1065–74. PMID 10586206. http://www.haematologica.org/cgi/reprint/84/12/1065. 
  4. ^ Horsti J, Uppa H, Vilpo JA (March 2005). "Poor agreement among prothrombin time international normalized ratio methods: comparison of seven commercial reagents". Clin. Chem. 51 (3): 553–60. doi:10.1373/clinchem.2004.043836. PMID 15665046. http://www.clinchem.org/cgi/content/full/51/3/553. 
  5. ^ a b Jackson CM, Esnouf MP (March 2005). "Has the time arrived to replace the quick prothrombin time test for monitoring oral anticoagulant therapy?". Clin. Chem. 51 (3): 483–5. doi:10.1373/clinchem.2004.045393. PMID 15738512. http://www.clinchem.org/cgi/content/full/51/3/483. 
  6. ^ Poller L, Keown M, Chauhan N, et al. (September 2003). "European Concerted Action on Anticoagulation. Correction of displayed international normalized ratio on two point-of-care test whole-blood prothrombin time monitors (CoaguChek Mini and TAS PT-NC) by independent international sensitivity index calibration". Br. J. Haematol. 122 (6): 944–9. doi:10.1046/j.1365-2141.2003.04521.x. PMID 12956765. 
  7. ^ Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P (February 2006). "Self-monitoring of oral anticoagulation: a systematic review and meta-analysis". Lancet 367 (9508): 404–11. doi:10.1016/S0140-6736(06)68139-7. PMID 16458764. 
  8. ^ Jack Ansell (10 March 2005). "Guidelines for implementation of patient self-testing and patient self-management of oral anticoagulation. International consensus guidelines prepared by International Self-Monitoring Association for Oral Anticoagulation". International Journal of Cardiology. http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6T16-4CVR7GB-2&_user=10&_coverDate=03%2F10%2F2005&_rdoc=1&_fmt=&_orig=search&_sort=d&view=c&_acct=C000050221&_version=1&_urlVersion=0&_userid=10&md5=31d380c38e3d5afdba3f7dbb04e8b5b7. 
  9. ^ "Medicare expands coverage for home blood testing of prothrombin time international normalized ratio". The Centers for Medicare and Medicaid Services. 19 March 2008. http://www.cms.hhs.gov/apps/media/press/release.asp?Counter=2987. 
  10. ^ Quick AJ, Stanley-Brown M, Bancroft FW (1935). "A study of the coagulation defect in hemophilia and in jaundice". Am J Med Sci 190: 501. doi:10.1097/00000441-193510000-00009. 
  11. ^ Owren PA, Aas K (1951). "The control of dicumarol therapy and the quantitative determination of prothrombin and proconvertin". Scand. J. Clin. Lab. Invest. 3 (3): 201–8. doi:10.3109/00365515109060600. PMID 14900966. 
  12. ^ Campbell HA, Smith WK, Roberts WL, Link KP (1941). "Studies on the hemorrhagic sweet clover disease. II. The bioassay of hemorrhagic concentrates by following the prothrombin level in the plasma of rabbit blood". J Biol Chem 138: 1–20. 
  13. ^ Hirsh J, Bates SM (March 2001). "Clinical trials that have influenced the treatment of venous thromboembolism: a historical perspective" (PDF). Ann. Intern. Med. 134 (5): 409–17. PMID 11242501. http://www.annals.org/cgi/content/full/134/5/409. 
  14. ^ Anonymous (1983). "33: Expert Committee on Biological Standardization. Requirements for thromboplastins and plasma used to control oral anticoagulant therapy". World Health Organ Tech Rep Ser. pp. 81–105.
GT:1.228